This centre is part of a larger initiative called “Next Generation Healthcare”, carried out by the University. I also include the use of artificial intelligence, robotics, gene editing and wearable sensors.
The Icahn School of Medicine of the famous Mount Sinai Hospital in Manhattan announces the creation of a centre for biomedical research to evaluate the potential uses of blockchain technology in the healthcare sector starting with the New York hospital.
The aim of the centre is to start discussions about the medicine of the future and on new technologies from a generic level to an academic one.
As the Director of Data Processing of the Noah Zimmerman Institute explained: “We want to balance that out. That’s what we’re adding as an academic medical centre joining the fray.”
Comparing his own research with ongoing research at MIT and IBM, Zimmerman added:
“The thing that differentiates this is that this is not just an academic centre but an academic medical centre and we’re the first people to drill into the biomedical and health care use cases for blockchain as a focus area.”
Joel Dudley, Executive Vice President of the centre, explained the purpose of the research: “This experience will allow us to address many of the most promising uses for blockchain in biomedicine with the goal of improving healthcare delivery and reducing costs. Many companies are already exploring the use of blockchain technologies in biology and healthcare.”
The researchers working at the research centre will also have the opportunity to develop personal projects in financial collaboration with private entities, thus significantly broadening the scope of action.
Mount Sinai in Manhattan is one of the city’s oldest and largest hospitals.
It was founded in the first half of the 19th century by Jewish benefactors to assist a large number of immigrants who came to Manhattan at the time and has since developed into the Icahn University Medical Institute.